PBE Holdings Information

PBE is an equity ETF with a total of 33 individual holdings. The top holdings are United Therapeutics stock at 6.03%, Illumina at 5.66%, Biogen at 4.92%, Incyte at 4.85%, and Regeneron Pharmaceuticals at 4.61%.

Total Holdings

Top 10 Percentage

46.79%

Asset Class

Equity

ETF Category

Health

Assets

254.56M

PE Ratio

18.88

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	UTHR	United Therapeutics Corporation	6.03%	27,038
2	ILMN	Illumina, Inc.	5.66%	104,158
3	BIIB	Biogen Inc.	4.92%	65,601
4	INCY	Incyte Corporation	4.85%	126,679
5	REGN	Regeneron Pharmaceuticals, Inc.	4.61%	16,576
6	GILD	Gilead Sciences, Inc.	4.56%	86,702
7	ALNY	Alnylam Pharmaceuticals, Inc.	4.46%	38,458
8	AMGN	Amgen Inc.	4.31%	33,435
9	TGTX	TG Therapeutics, Inc.	3.86%	228,853
10	CPRX	Catalyst Pharmaceuticals, Inc.	3.53%	288,645
11	ARWR	Arrowhead Pharmaceuticals, Inc.	3.35%	109,664
12	BCRX	BioCryst Pharmaceuticals, Inc.	3.20%	917,520
13	NBIX	Neurocrine Biosciences, Inc.	3.13%	53,314
14	VCYT	Veracyte, Inc.	3.13%	195,637
15	PTGX	Protagonist Therapeutics, Inc.	3.10%	79,897
16	CDNA	CareDx, Inc.	3.05%	362,717
17	RPRX	Royalty Pharma plc	3.03%	153,795
18	EXEL	Exelixis, Inc.	2.80%	154,680
19	RGEN	Repligen Corporation	2.57%	51,847
20	PTCT	PTC Therapeutics, Inc.	2.56%	101,221
21	HALO	Halozyme Therapeutics, Inc.	2.54%	99,238
22	VCEL	Vericel Corporation	2.51%	182,544
23	ACAD	ACADIA Pharmaceuticals Inc.	2.51%	283,949
24	TBPH	Theravance Biopharma, Inc.	2.44%	366,332
25	IONS	Ionis Pharmaceuticals, Inc.	2.43%	81,712

Showing 25 of 33 holdings

Subscribe to see the full list

Activate Now

As of May 7, 2026